Kim Lyerly

33PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 01, 2026
P95-HER2 promotes metastatic progression by biasing MRTFA dependent signaling.

|May 07, 2026
Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy.

|Dec 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity.

Bin-Jin Hwang, Erika J Crosby, David T Severson

|Apr 02, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd).

Li-Chung Tsao, John S Wang, Xingru Ma

|Mar 19, 2025
Nonlinear progression during the occult transition establishes cancer lethality.

Joshua D Ginzel, Henry Chapman, Joelle E Sills

|Nov 26, 2024
Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer.

Robert D Marek, Selena Halabi, Mu-En Wang

Pageof 6

Frequent Collaborators

16 joint publications

Zachary Conrad Hartman

10 joint publications

Erika J Crosby

8 joint publications

Chaitanya R Acharya

7 joint publications

Joshua C Snyder